Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
Infinity Pharmaceuticals (NASDAQ: INFI) got off to a market-beating start this week as its shares zoomed 3.8% higher Monday, on the back of new analyst coverage that made an extremely bullish case for investing in the biotech.
H.C. Wainwright's Michael King Jr. is the prominent new Infinity bull. He unhesitatingly tagged the stock with a buy recommendation at a price target of $9 per share. That's more than triple the current share price, even after Monday's pop.
Image source: Getty Images.
Source Fool.com
